Protalix BioTherapeutics
PLX
#8915
Rank
โ‚ฌ0.11 B
Marketcap
1,48ย โ‚ฌ
Share price
-2.79%
Change (1 day)
-11.09%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): 0,01526ย โ‚ฌ

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is 0,01702ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of 0,03403ย โ‚ฌ a decrease over its 2023 EPS that were of 0,10ย โ‚ฌ.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)0,01526ย โ‚ฌ-55.15%
20240,03403ย โ‚ฌ-66.67%
20230,10ย โ‚ฌ-138.71%
2022-0,26ย โ‚ฌ-50%
2021-0,53ย โ‚ฌ181.82%
2020-0,19ย โ‚ฌ-82.11%
2019-1,05ย โ‚ฌ-31.67%
2018-1,53ย โ‚ฌ-72.31%
2017-5,53ย โ‚ฌ124.14%
2016-2,47ย โ‚ฌ-147.54%
20155,19ย โ‚ฌ-290.63%
2014-2,72ย โ‚ฌ6.67%
2013-2,55ย โ‚ฌ130.77%
2012-1,11ย โ‚ฌ-69.77%
2011-3,66ย โ‚ฌ19.44%
2010-3,06ย โ‚ฌ-12.2%
2009-3,49ย โ‚ฌ36.67%
2008-2,55ย โ‚ฌ-37.5%
2007-4,08ย โ‚ฌ50%
2006-2,72ย โ‚ฌ3.23%
2005-2,64ย โ‚ฌ138.46%
2004-1,11ย โ‚ฌ-74%
2003-4,25ย โ‚ฌ-0%
2002-4,25ย โ‚ฌ-50%
2001-8,51ย โ‚ฌ233.33%
2000-2,55ย โ‚ฌ-84.06%
1999-16,01ย โ‚ฌ-24%
1998-21,07ย โ‚ฌ-600%
19974,21ย โ‚ฌ-16.67%
19965,06ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-0,09359ย โ‚ฌ-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
3,67ย โ‚ฌ 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,46ย โ‚ฌ 8,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,54ย โ‚ฌ 3,050.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel